Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Carcinoma, Intraductal, Noninfiltrating × sargramostim × 1 year × Clear all

Sponsor

Conditions

Neuroblastoma 11 Ganglioneuroblastoma 4 Triple Negative Breast Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Transplant-Related Hematologic Malignancy 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Alveolar Soft Part 1 Recurrence 1 Pathologic Complete Response 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma 1 Locally Advanced Pancreatic Adenocarcinoma 1 Leukemia, Plasma Cell 1 Leukemia, Myeloid, Acute 1 Leukemia 1 Hodgkin Disease 1 Gliosarcoma 1 Glioblastoma 1 Endometrial Neoplasms 1 Carcinosarcoma 1

Interventions

Specimen Handling 8 Tamoxifen 7 Radiotherapy 5 exemestane 3 Radiation 3 Letrozole 3 Anastrozole 3 Surveys and Questionnaires 2 Sentinel Lymph Node Biopsy 2 Radiation Dose Hypofractionation 2 Patient Navigation 2 Observation 2 Metformin 2 Mastectomy 2 Magnetic Resonance Spectroscopy 2 Biopsy 2 trastuzumab biosimilar HLX02 1 poly ICLC 1 palbociclib 1 fezolinetant 1 elacestrant 1 afimoxifene 1 abemaciclib 1 Trastuzumab 1 Testosterone 1 Tablets 1 Surgical Procedures, Operative 1 Steroids 1 Standard of Care 1 Selective Estrogen Receptor Modulators 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡